Your browser doesn't support javascript.
loading
Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.
Ameriso, Sebastian F; Amarenco, Pierre; Pearce, Lesly A; Perera, Kanjana S; Ntaios, George; Lang, Wilfried; Bereczki, Daniel; Uchiyama, Shinichiro; Kasner, Scott E; Yoon, Byung-Woo; Lavados, Pablo; Firstenfeld, Alfredo; Mikulik, Robert; Povedano, Guillermo Pablo; Ferrari, Jorge; Mundl, Hardi; Berkowitz, Scott D; Connolly, Stuart J; Hart, Robert G.
Affiliation
  • Ameriso SF; Institute for Neurological Research-FLENI, Buenos Aires, Argentina. Electronic address: sameriso@fleni.org.ar.
  • Amarenco P; Department of Neurology, Bichat Hospital, Paris University, Paris, France.
  • Pearce LA; Biostatistics Consultant, Minot, ND, USA.
  • Perera KS; Department of Medicine (Neurology), McMaster University/Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Ntaios G; Department of Medicine, University of Thessaly, Larissa, Greece.
  • Lang W; Medical Faculty, Hospital St. John of God, Sigmund Freud Private University, Vienna, Austria.
  • Bereczki D; Department of Neurology, Semmelweis University, Budapest, Hungary.
  • Uchiyama S; International University of Health and Welfare, Sanno Hospital and Sanno Medical Center, Tokyo, Japan.
  • Kasner SE; Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
  • Yoon BW; Department of Neurology, Seoul National University Hospital, Seoul, Korea.
  • Lavados P; Clinica Alemana de Santiago, Universidad del Desarrollo, Santiago, Chile.
  • Firstenfeld A; Instituto Cardiologico Banfield, Buenos Aires, Argentina.
  • Mikulik R; International Clinical Research Center and Neurology Department, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic.
  • Povedano GP; Complejo Medico de la PFA Churruca Visca, Buenos Aires, Argentina.
  • Ferrari J; Hospital Interzonal General de Agudos Eva Peron, Buenos Aires, Argentina.
  • Mundl H; Bayer AG, Wuppertal, Germany.
  • Berkowitz SD; Pharmaceuticals Clinical Development Thrombosis, Bayer U.S. LLC, Whippany, NJ, USA.
  • Connolly SJ; Department of Medicine (Cardiology), McMaster University / Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Hart RG; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
J Stroke Cerebrovasc Dis ; 29(8): 104936, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32689594
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Platelet Aggregation Inhibitors / Intracranial Arteriosclerosis / Aspirin / Stroke / Intracranial Embolism / Peripheral Arterial Disease / Fibrinolytic Agents / Factor Xa Inhibitors / Rivaroxaban Type of study: Clinical_trials / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Stroke Cerebrovasc Dis Year: 2020 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Platelet Aggregation Inhibitors / Intracranial Arteriosclerosis / Aspirin / Stroke / Intracranial Embolism / Peripheral Arterial Disease / Fibrinolytic Agents / Factor Xa Inhibitors / Rivaroxaban Type of study: Clinical_trials / Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Stroke Cerebrovasc Dis Year: 2020 Type: Article